< Back to previous page
Researcher
Frank Peelman
- Disciplines:Palliative care and end-of-life care, Laboratory medicine, Other translational sciences, Regenerative medicine, Nursing, Other clinical sciences, Other basic sciences, Other paramedical sciences, Other health sciences, Other medical and health sciences
Affiliations
- Department of Biomolecular Medicine (Department)
Member
From1 Oct 2018 → Today - Department of Biochemistry (Department)
Member
From1 Oct 1994 → 30 Sep 2018
Projects
1 - 6 of 6
- In-depth study of structure/activity relations of the glucocorticoid receptor and its ligands via an extreme mutation scanFrom1 Nov 2023 → TodayFunding: BOF - doctoral mandates
- Prepared for SARS-CoV-3: advancing our understanding of SARS coronavirus antigenic and pathogenic evolutionFrom1 Jan 2022 → TodayFunding: FWO EOS
- A bioinformatic toolbox for the analysis and optimization of a high-throughput deep mutational scanning assay: development and case-studyFrom1 Nov 2020 → TodayFunding: FWO fellowships
- In-depth study of structure/activity relations of the glucocorticoid receptor and its ligands via an extreme mutation scan.From1 Nov 2019 → 31 Oct 2023Funding: FWO Strategic Basic Research Grant
- Development of a robust expression system for stable soluble influenza neuraminidaseFrom1 Nov 2019 → 31 Oct 2023Funding: FWO Strategic Basic Research Grant
- Bioinformatics for a high-throughput deep mutational scanning protein-protein interaction assay: turning a prototype into a precision medicine toolboxFrom1 Oct 2019 → 31 Oct 2020Funding: BOF - doctoral mandates
Publications
11 - 11 of 11
- Elongin B/C recruitment regulates substrate binding by CIS(2008)
Authors: Julie Piessevaux, Leentje De Ceuninck, Dominiek Catteeuw, Frank Peelman, Jan Tavernier
Pages: 21334 - 21346
Patents
1 - 10 of 10
- TARGETED MUTANT INTERFERON-GAMMA AND USES THEREOF (Inventor)
- TARGETED MUTANT INTERFERON-GAMMA AND USES THEREOF (Inventor)
- NOVEL TSLP INHIBITORS (Inventor)
- TARGETED MUTANT INTERFERON-β USES THEREOF (Inventor)
- TARGETING OF CYTOKINE ANTAGONISTS (Inventor)
- TARGETED MODIFIED IL-1 FAMILY MEMBERS (Inventor)
- TARGETED MODIFIED TNF FAMILY MEMBERS (Inventor)
- TARGETED MUTANT INTERFERON-GAMMA AND USES THEREOF (Inventor)
- TARGETED MODIFIED IL-1 FAMILY MEMBERS (Inventor)
- TARGETED MODIFIED TNF FAMILY MEMBERS (Inventor)